| scholarly article | Q13442814 |
| P50 | author | Lestat R. Ali | Q61479053 |
| Stephanie K Dougan | Q87642804 | ||
| P2093 | author name string | Michael B Brenner | |
| Lydia Lynch | |||
| Eleanor Clancy-Thompson | |||
| Hee-Jin Jeong | |||
| Stephanie J Crowley | |||
| Nelson M LaMarche | |||
| Gui Zhen Chen | |||
| Kelly Boelaars | |||
| P2860 | cites work | Microbial exposure during early life has persistent effects on natural killer T cell function | Q24604308 |
| Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virus | Q24630276 | ||
| Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen | Q28589275 | ||
| A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells | Q30435569 | ||
| Invariant NKT cells sustain specific B cell responses and memory | Q30479030 | ||
| Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop. | Q33618864 | ||
| Protective mucosal immunity mediated by epithelial CD1d and IL-10. | Q34045485 | ||
| Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. | Q34144392 | ||
| Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions | Q34323476 | ||
| Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response | Q34493722 | ||
| Direct incorporation of the NKT-cell activator α-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy | Q34499626 | ||
| Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination | Q34517948 | ||
| Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue | Q35129219 | ||
| Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice | Q36113612 | ||
| Cognate interaction with iNKT cells expands IL-10-producing B regulatory cells | Q36155364 | ||
| IgG1+ ovalbumin-specific B-cell transnuclear mice show class switch recombination in rare allelically included B cells | Q36187228 | ||
| The immunologic functions of the neonatal Fc receptor for IgG | Q36542347 | ||
| Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4(+) T cell help | Q36573926 | ||
| NK T cells provide lipid antigen-specific cognate help for B cells | Q36751506 | ||
| B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo | Q36751511 | ||
| Peyer's patches: organizing B-cell responses at the intestinal frontier | Q36810325 | ||
| Innate-like functions of natural killer T cell subsets result from highly divergent gene programs | Q37094372 | ||
| Lower TCR repertoire diversity in Traj18-deficient mice | Q37108326 | ||
| Cd1d-dependent regulation of bacterial colonization in the intestine of mice | Q37170819 | ||
| Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. | Q37191048 | ||
| Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells | Q37298525 | ||
| Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner | Q37322505 | ||
| Transnuclear TRP1-specific CD8 T cells with high or low affinity TCRs show equivalent antitumor activity | Q37494158 | ||
| Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells | Q37539899 | ||
| Invariant NKT cells provide innate and adaptive help for B cells. | Q38186944 | ||
| iNKT-cell help to B cells: a cooperative job between innate and adaptive immune responses | Q38208261 | ||
| Interplay between the immune system and adipose tissue in obesity | Q38250282 | ||
| The transcriptional programs of iNKT cells. | Q38405427 | ||
| Glycolipid activators of invariant NKT cells as vaccine adjuvants | Q38885794 | ||
| Monoclonal Invariant NKT (iNKT) Cell Mice Reveal a Role for Both Tissue of Origin and the TCR in Development of iNKT Functional Subsets. | Q40174608 | ||
| IL-9 Expression by Invariant NKT Cells Is Not Imprinted during Thymic Development. | Q40617067 | ||
| Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy | Q40618967 | ||
| IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset | Q42141575 | ||
| Role of Granulocyte-Macrophage Colony-Stimulating Factor Production by T Cells during Mycobacterium tuberculosis Infection | Q42638867 | ||
| Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells | Q44217456 | ||
| NKT-cell help to B lymphocytes can occur independently of cognate interaction. | Q45880618 | ||
| NKT Cell-Deficient Mice Harbor an Altered Microbiota That Fuels Intestinal Inflammation during Chemically Induced Colitis. | Q46466761 | ||
| Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells | Q47242113 | ||
| Prophylactic Sublingual Immunization with Mycobacterium tuberculosis Subunit Vaccine Incorporating the Natural Killer T Cell Agonist Alpha-Galactosylceramide Enhances Protective Immunity to Limit Pulmonary and Extra-Pulmonary Bacterial Burden in Mic | Q47324477 | ||
| IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells | Q47350839 | ||
| iNKT Cells Orchestrate a Switch from Inflammation to Resolution of Sterile Liver Injury | Q47632595 | ||
| Co-localization of a CD1d-binding glycolipid with an adenovirus-based malaria vaccine for a potent adjuvant effect | Q47993724 | ||
| CD1d-mediated lipid presentation by CD11c+ cells regulates intestinal homeostasis | Q48148150 | ||
| Discrete TCR Binding Kinetics Control Invariant NKT Cell Selection and Central Priming. | Q48261213 | ||
| Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy. | Q52645931 | ||
| Dietary and Microbial Oxazoles Induce Intestinal Inflammation by Modulating Aryl Hydrocarbon Receptor Responses. | Q53818378 | ||
| Activation and Regulation of B Cell Responses by Invariant Natural Killer T Cells. | Q55398868 | ||
| Altered thymic differentiation and modulation of arthritis by invariant NKT cells expressing mutant ZAP70. | Q55510136 | ||
| Identification of Regulatory Foxp3+ Invariant NKT Cells Induced by TGF- | Q59309404 | ||
| Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses | Q60311662 | ||
| TCR signal strength controls thymic differentiation of iNKT cell subsets | Q61137128 | ||
| Tissue-specific functions of invariant natural killer T cells | Q63362826 | ||
| IL-9-producing invariant NKT cells protect against DSS-induced colitis in an IL-4-dependent manner | Q84795718 | ||
| Characterization of Thymic Development of Natural Killer T Cell Subsets by Multiparameter Flow Cytometry | Q89339104 | ||
| How Lipid-Specific T Cells Become Effectors: The Differentiation of iNKT Subsets | Q89576459 | ||
| A common transcriptomic program acquired in the thymus defines tissue residency of MAIT and NKT subsets | Q90286722 | ||
| P4510 | describes a project that uses | DESeq2 | Q113018293 |
| P433 | issue | 14 | |
| P304 | page(s) | e101260 | |
| P577 | publication date | 2019-05-31 | |
| P1433 | published in | The EMBO Journal | Q1278554 |
| P1476 | title | Transnuclear mice reveal Peyer's patch iNKT cells that regulate B-cell class switching to IgG1 | |
| P478 | volume | 38 |
Search more.